Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cardiogenic Shock
99%
Impella
32%
Heart Failure
30%
Left Ventricular Assist Device
24%
Group Reports
22%
Heart Transplant Recipients
22%
Mechanical Circulatory Support
18%
Clinical Outcomes
17%
Shock Severity
16%
Continuous Flow
14%
Tissue Plasminogen Activator (t-PA)
14%
Shock Patient
13%
Temporary Mechanical Circulatory Support
10%
In-hospital Mortality
10%
Intra-aortic Balloon Pump
9%
Patients with Heart Failure
9%
In-hospital Death
9%
Angiography
9%
Gastrointestinal Bleeding
8%
Heart Transplantation
8%
Alteplase
8%
Clinical Course
8%
Purge Solution
8%
ST-elevation Myocardial Infarction (STEMI)
8%
High Mortality Rate
8%
Anticoagulation
8%
Risk Stratification
8%
Treatment Intensity
8%
Advanced Therapies
7%
Ventricular Assist Device
7%
Renal Function Improvement
7%
Therapeutic Implications
7%
Bloodstream Infection
7%
Shock Outcome
7%
Pulmonary Artery Catheter
7%
Cardiac Intensive Care Unit
7%
Left Ventricular Assist
7%
Single-center Study
7%
Heart Failure Etiology
7%
Prolonged Use
7%
Durable LVAD
7%
Right Ventricular Adaptation
7%
Adaptation Measures
7%
Non-STEMI
7%
Coagulation Abnormalities
7%
Collapse Therapy
7%
Percutaneous Right Ventricular Assist Device
7%
Bicarbonate
7%
Ventricular Assist Device Therapy
7%
Clinical Presentation
7%
Medicine and Dentistry
Cardiogenic Shock
100%
Congestive Heart Failure
43%
Left Ventricular Assist Device
31%
Assisted Circulation
30%
Ventricular Assist Device
22%
Infection
16%
Heart Graft
15%
Tissue Plasminogen Activator
14%
Mortality Rate
10%
Hospital Mortality
10%
Apoplexy
10%
Intra-Aortic Balloon Pump
9%
Angiography
9%
Pathophysiology
9%
Cardiovascular System
9%
Gastrointestinal Bleeding
8%
Alteplase
8%
Disease Course
8%
Heart Right Ventricle Failure
8%
Anticoagulation
8%
Advanced Therapy
7%
Risk Stratification
7%
Non ST Segment Elevation Myocardial Infarction
7%
Shock (Circulatory)
7%
Pulmonary Artery Catheter
7%
Thrombosis
7%
COVID-19
7%
Regulatory T Cell
7%
Intravascular Hemolysis
7%
RNA Sequence
7%
Cannula
7%
Device Therapy
7%
Tertiary Care
7%
Coronary Artery Disease
7%
Sodium Bicarbonate
7%
Bloodstream Infection
7%
Immunoglobulin G
7%
Immunoglobulin
7%
Hypogammaglobulinemia
7%
Critical Limb Ischemia
7%
Kidney Function
7%
Coronary Care Unit
7%
Intervention Stage
7%
Acute Heart Infarction
6%
Heart Transplantation
5%
Primary Outcome
5%